Experts from Moderna, Revelation Pharma, and Alexion offer ways to reduce risks, improve real-time visibility, and ensure ...

According to a new national poll from the PAN Foundation’s Center for Patient Research, 1 in the past 12 months, more than ...

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could ...

Amid pressures on pharma to match the lowest international prices, experts warn of “policy laundering” and discriminatory ...

Dave Malenfant, healthcare supply chain expert, gives his sneak peak into LogiPharma USA.

This episode of Pharma Pulse covers ATA’s warning that telehealth protections are critical to maintaining care access during a potential federal shutdown, new KFF data showing the rapid rise of ...

Dave Malenfant, healthcare supply chain expert, gives his sneak peak into LogiPharma 2025.

How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of ...

Dave Malenfant, healthcare supply chain expert, discusses the ramifications of a 100% tariff on branded and patented drugs entering the US.

Bayer’s Luiz Barberini highlights how artificial intelligence is transforming supply chain operations, while emphasizing the ...

This episode of Pharma Pulse covers the Trump administration’s plan to launch a government-run healthcare website for patients, new data showing gabapentin has become the fifth most prescribed drug in ...

Supply chain leaders share strategies to address persistent drug shortages, highlighting vulnerabilities, manufacturing ...